Skip to content

Source filing unavailable

Q4 2020 · —

derived · Computed from the longer spans the company filed.

Revenue$0.00derivedno prior Q4 2019 on file−100.0% vs Q3 2020
Net Income-$17.19Mderivedno prior Q4 2019 on fileN/M vs Q3 2020
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$17,477,000—
Operating Cash Flowderived-$16,823,000—
Free Cash Flowderived-$62,094,000—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q4 2019 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Instil Bio, Inc. · CIK 1789769 · Engraved from SEC EDGAR